1
|
Aminzadeh A, Hilgers L, Paul Platenburg P, Riou M, Perrot N, Rossignol C, Cauty A, Barc C, Jørgensen R. Immunogenicity and safety in rabbits of a Clostridioides difficile vaccine combining novel toxoids and a novel adjuvant. Vaccine 2024; 42:1582-1592. [PMID: 38336558 DOI: 10.1016/j.vaccine.2024.01.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 12/12/2023] [Accepted: 01/23/2024] [Indexed: 02/12/2024]
Abstract
Clostridioides difficile infection (CDI) is a serious healthcare-associated disease, causing symptoms such as diarrhea and pseudomembranous colitis. The major virulence factors responsible for the disease symptoms are two secreted cytotoxic proteins, TcdA and TcdB. A parenteral vaccine based on formaldehyde-inactivated TcdA and TcdB supplemented with alum adjuvant, has previously been investigated in humans but resulted in an insufficient immune response. In search for an improved response, we investigated a novel toxin inactivation method and a novel, potent adjuvant. Inactivation of toxins by metal-catalyzed oxidation (MCO) was previously shown to preserve neutralizing epitopes and to annihilate reversion to toxicity. The immunogenicity and safety of TcdA and TcdB inactivated by MCO and combined with a novel carbohydrate fatty acid monosulphate ester-based (CMS) adjuvant were investigated in rabbits. Two or three intramuscular immunizations generated high serum IgG and neutralizing antibody titers against both toxins. The CMS adjuvant increased antibody responses to both toxins while an alum adjuvant control was effective only against TcdA. Systemic safety was evaluated by monitoring body weight, body temperature, and analysis of red and white blood cell counts shortly after immunization. Local safety was assessed by histopathologic examination of the injection site at the end of the study. Body weight gain was constant in all groups. Body temperature increased up to 1 ˚C one day after the first immunization but less after the second or third immunization. White blood cell counts, and percentage of neutrophils increased one day after immunization with CMS-adjuvanted vaccines, but not with alum. Histopathology of the injection sites 42 days after the last injection did not reveal any abnormal tissue reactions. From this study, we conclude that TcdA and TcdB inactivated by MCO and combined with CMS adjuvant demonstrated promising immunogenicity and safety in rabbits and could be a candidate for a vaccine against CDI.
Collapse
Affiliation(s)
- Aria Aminzadeh
- Proxi Biotech ApS, Egeskellet 6, 2000 Frederiksberg, Denmark; Department of Science and Environment, University of Roskilde, 4000 Roskilde, Denmark
| | - Luuk Hilgers
- LiteVax BV, Akkersestraat 50, 4061BJ Ophemert, the Netherlands
| | | | - Mickaël Riou
- INRAE, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), Centre Val de Loire, 37380 Nouzilly, France
| | - Noémie Perrot
- INRAE, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), Centre Val de Loire, 37380 Nouzilly, France
| | - Christelle Rossignol
- INRAE-Université de Tours, UMR-1282 Infectiologie et Santé publique (ISP), équipe IMI, Centre Val de Loire, 37380 Nouzilly, France
| | - Axel Cauty
- INRAE, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), Centre Val de Loire, 37380 Nouzilly, France
| | - Céline Barc
- INRAE, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), Centre Val de Loire, 37380 Nouzilly, France
| | - René Jørgensen
- Proxi Biotech ApS, Egeskellet 6, 2000 Frederiksberg, Denmark; Department of Science and Environment, University of Roskilde, 4000 Roskilde, Denmark.
| |
Collapse
|
2
|
León-Janampa N, Caballero-Posadas I, Barc C, Darrouzain F, Moreau A, Guinoiseau T, Gatault P, Fleurot I, Riou M, Pinard A, Pezant J, Rossignol C, Gaudy-Graffin C, Brand D, Marlet J. A pig model of chronic hepatitis E displaying persistent viremia and a downregulation of innate immune responses in the liver. Hepatol Commun 2023; 7:e0274. [PMID: 37938097 PMCID: PMC10635601 DOI: 10.1097/hc9.0000000000000274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Accepted: 06/27/2023] [Indexed: 11/09/2023] Open
Abstract
BACKGROUND Hepatitis E virus (HEV) is a zoonotic virus transmitted by pig meat and responsible for chronic hepatitis E in immunocompromised patients. It has proved challenging to reproduce this disease in its natural reservoir. We therefore aimed to develop a pig model of chronic hepatitis E to improve the characterization of this disease. METHODS Ten pigs were treated with a tacrolimus-based regimen and intravenously inoculated with HEV. Tacrolimus trough concentration, HEV viremia, viral diversity, innate immune responses, liver histology, clinical disease and biochemical markers were monitored for 11 weeks post-infection (p.i.). RESULTS HEV viremia persisted for 11 weeks p.i. HEV RNA was detected in the liver, small intestine, and colon at necropsy. Histological analysis revealed liver inflammation and fibrosis. Several mutations selected in the HEV genome were associated with compartmentalization in the feces and intestinal tissues, consistent with the hypothesis of extrahepatic replication in the digestive tract. Antiviral responses were characterized by a downregulation of IFN pathways in the liver, despite an upregulation of RIG-I and ISGs in the blood and liver. CONCLUSIONS We developed a pig model of chronic hepatitis E that reproduced the major hallmarks of this disease. This model revealed a compartmentalization of HEV genomes in the digestive tract and a downregulation of innate immune responses in the liver. These original features highlight the relevance of our model for studies of the pathogenesis of chronic hepatitis E and for validating future treatments.
Collapse
Affiliation(s)
- Nancy León-Janampa
- INSERM U1259 MAVIVH, Tours University and Tours University Hospital, Tours, France
| | | | - Céline Barc
- UE-1277 Platform for Experimentation on Infectious Diseases, INRAe, Nouzilly, France
| | - François Darrouzain
- Department of Pharmacology and Toxicology, Tours University Hospital, Tours, France
| | - Alain Moreau
- INSERM U1259 MAVIVH, Tours University and Tours University Hospital, Tours, France
| | - Thibault Guinoiseau
- Department of Bacteriology-Virology-Hygiene, Tours University Hospital, Tours, France
| | - Philippe Gatault
- Department of Nephrology and Transplantation, Tours University Hospital, Tours, France
- EA4245, University of Tours, Tours, France
| | | | - Mickaël Riou
- UE-1277 Platform for Experimentation on Infectious Diseases, INRAe, Nouzilly, France
| | - Anne Pinard
- UE-1277 Platform for Experimentation on Infectious Diseases, INRAe, Nouzilly, France
| | - Jérémy Pezant
- UE-1277 Platform for Experimentation on Infectious Diseases, INRAe, Nouzilly, France
| | | | - Catherine Gaudy-Graffin
- INSERM U1259 MAVIVH, Tours University and Tours University Hospital, Tours, France
- Department of Bacteriology-Virology-Hygiene, Tours University Hospital, Tours, France
| | - Denys Brand
- INSERM U1259 MAVIVH, Tours University and Tours University Hospital, Tours, France
- Department of Bacteriology-Virology-Hygiene, Tours University Hospital, Tours, France
| | - Julien Marlet
- INSERM U1259 MAVIVH, Tours University and Tours University Hospital, Tours, France
- Department of Bacteriology-Virology-Hygiene, Tours University Hospital, Tours, France
| |
Collapse
|
3
|
López-Gálvez R, Fleurot I, Chamero P, Trapp S, Olivier M, Chevaleyre C, Barc C, Riou M, Rossignol C, Guillon A, Si-Tahar M, May T, Barbry P, Bähr A, Klymiuk N, Sirard JC, Caballero I. Airway Administration of Flagellin Regulates the Inflammatory Response to Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 2021; 65:378-389. [PMID: 34102087 PMCID: PMC8525202 DOI: 10.1165/rcmb.2021-0125oc] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Excessive lung inflammation and airway epithelial damage are hallmarks of human inflammatory lung diseases, such as cystic fibrosis (CF). Enhancement of innate immunity provides protection against pathogens while reducing lung-damaging inflammation. However, the mechanisms underlying innate immunity–mediated protection in the lung remain mysterious, in part because of the lack of appropriate animal models for these human diseases. TLR5 (Toll-like receptor 5) stimulation by its specific ligand, the bacterial protein flagellin, has been proposed to enhance protection against several respiratory infectious diseases, although other cellular events, such as calcium signaling, may also control the intensity of the innate immune response. Here, we investigated the molecular events prompted by stimulation with flagellin and its role in regulating innate immunity in the lung of the pig, which is anatomically and genetically more similar to humans than rodent models. We found that flagellin treatment modulated NF-κB signaling and intracellular calcium homeostasis in airway epithelial cells. Flagellin pretreatment reduced the NF-κB nuclear translocation and the expression of proinflammatory cytokines to a second flagellin stimulus as well as to Pseudomonas aeruginosa infection. Moreover, in vivo administration of flagellin decreased the severity of P. aeruginosa–induced pneumonia. Then we confirmed these beneficial effects of flagellin in a pathological model of CF by using ex vivo precision-cut lung slices from a CF pigz model. These results provide evidence that flagellin treatment contributes to a better regulation of the inflammatory response in inflammatory lung diseases such as CF.
Collapse
Affiliation(s)
| | | | - Pablo Chamero
- INRAE, 27057, Laboratoire de Physiologie de la Reproduction et des Comportements UMR 0085 INRAE/CNRS/IFCE/Université de Tours, Nouzilly, France
| | - Sascha Trapp
- INRAE, 27057, Infectiologie et Santé Publique, Nouzilly, France
| | - Michel Olivier
- INRAE, 27057, Infectiologie et Santé Publique, Nouzilly, France
| | | | - Céline Barc
- INRAE, UE-1277 Plateforme d'infectiologie expérimentale (PFIE), Centre de Recherche Val de Loire, Nouzilly, France
| | - Mickael Riou
- INRAE, 27057, UE-1277 Plateforme d'infectiologie expérimentale (PFIE), Centre de Recherche Val de Loire, Nouzilly, France
| | | | - Antoine Guillon
- INSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.,CHRU de Tours, service de médecine intensive - réanimation, Tours, France
| | - Mustapha Si-Tahar
- INSERM U1100 - Faculty of Medicine, Study Center for Respiratory Pathologies, Tours, France
| | | | - Pascal Barbry
- Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France.,CNRS, 27051, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
| | | | - Nikolai Klymiuk
- LMU, 9183, CIMM-Gene Center and Center for Innovative Medical Models, Munchen, Germany
| | - Jean-Claude Sirard
- Center for Infection and Immunity of Lille, 165209, Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 , Lille, France
| | | |
Collapse
|
4
|
Bernelin-Cottet C, Urien C, McCaffrey J, Collins D, Donadei A, McDaid D, Jakob V, Barnier-Quer C, Collin N, Bouguyon E, Bordet E, Barc C, Boulesteix O, Leplat JJ, Blanc F, Contreras V, Bertho N, Moore AC, Schwartz-Cornil I. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs. J Control Release 2019; 308:14-28. [PMID: 31265882 DOI: 10.1016/j.jconrel.2019.06.041] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2019] [Revised: 06/26/2019] [Accepted: 06/28/2019] [Indexed: 12/18/2022]
Abstract
DNA vaccination is an attractive technology, based on its well-established manufacturing process, safety profile, adaptability to rapidly combat pandemic pathogens, and stability at ambient temperature; however an optimal delivery method of DNA remains to be determined. As pigs are a relevant model for humans, we comparatively evaluated the efficiency of vaccine DNA delivery in vivo to pigs using dissolvable microneedle patches, intradermal inoculation with needle (ID), surface electroporation (EP), with DNA associated or not to cationic poly-lactic-co-glycolic acid nanoparticles (NPs). We used a luciferase encoding plasmid (pLuc) as a reporter and vaccine plasmids encoding antigens from the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a clinically-significant swine arterivirus. Patches were successful at inducing luciferase expression in skin although at lower level than EP. EP induced the cutaneaous recruitment of granulocytes, of MHC2posCD172Apos myeloid cells and type 1 conventional dendritic cells, in association with local production of IL-1β, IL-8 and IL-17; these local responses were more limited with ID and undetectable with patches. The addition of NP to EP especially promoted the recruitment of the MHC2posCD172Apos CD163int and CD163neg myeloid subsets. Notably we obtained the strongest and broadest IFNγ T-cell response against a panel of PRRSV antigens with DNA + NPs delivered by EP, whereas patches and ID were ineffective. The anti-PRRSV IgG responses were the highest with EP administration independently of NPs, mild with ID, and undetectable with patches. These results contrast with the immunogenicity and efficacy previously induced in mice with patches. This study concludes that successful DNA vaccine administration in skin can be achieved in pigs with electroporation and patches, but only the former induces local inflammation, humoral and cellular immunity, with the highest potency when NPs were used. This finding shows the importance of evaluating the delivery and immunogenicity of DNA vaccines beyond the mouse model in a preclinical model relevant to human such as pig and reveals that EP with DNA combined to NP induces strong immunogenicity.
Collapse
Affiliation(s)
| | - Céline Urien
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France
| | - Joanne McCaffrey
- School of Pharmacy, School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland; Xeolas Pharmaceuticals Ltd., Dublin, Ireland
| | - Damien Collins
- School of Pharmacy, School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland; Xeolas Pharmaceuticals Ltd., Dublin, Ireland
| | - Agnese Donadei
- School of Pharmacy, School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland; Xeolas Pharmaceuticals Ltd., Dublin, Ireland
| | | | - Virginie Jakob
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland
| | - Christophe Barnier-Quer
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland
| | - Nicolas Collin
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland
| | - Edwige Bouguyon
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France
| | - Elise Bordet
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France
| | | | | | - Jean-Jacques Leplat
- GABI, INRA-AgroParisTech, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France
| | - Fany Blanc
- GABI, INRA-AgroParisTech, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France
| | - Vanessa Contreras
- Immunology of viral infections and autoimmune diseases, IDMIT Department, IBFJ, INSERM U1184-CEA - Université Paris Sud 11, Fontenay-Aux-Roses et Le Kremlin-Bicêtre, France
| | - Nicolas Bertho
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France; BIOEPAR, Oniris, INRA, 44307 Nantes, France
| | - Anne C Moore
- School of Pharmacy, School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland
| | | |
Collapse
|
5
|
Bernelin-Cottet C, Urien C, Fretaud M, Langevin C, Trus I, Jouneau L, Blanc F, Leplat JJ, Barc C, Boulesteix O, Riou M, Dysart M, Mahé S, Studsrub E, Nauwynck H, Bertho N, Bourry O, Schwartz-Cornil I. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection. Viruses 2019; 11:E576. [PMID: 31242645 PMCID: PMC6631340 DOI: 10.3390/v11060576] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Revised: 06/18/2019] [Accepted: 06/21/2019] [Indexed: 12/24/2022] Open
Abstract
The porcine reproductive and respiratory syndrome virus (PRRSV), an RNA virus inducing abortion in sows and respiratory disease in young pigs, is a leading infectious cause of economic losses in the swine industry. Modified live vaccines (MLVs) help in controlling the disease, but their efficacy is often compromised by the high genetic diversity of circulating viruses, leading to vaccine escape variants in the field. In this study, we hypothesized that a DNA prime with naked plasmids encoding PRRSV antigens containing conserved T-cell epitopes may improve the protection of MLV against a heterologous challenge. Plasmids were delivered with surface electroporation or needle-free jet injection and European strain-derived PRRSV antigens were targeted or not to the dendritic cell receptor XCR1. Compared to MLV-alone, the DNA-MLV prime- boost regimen slightly improved the IFNγ T-cell response, and substantially increased the antibody response against envelope motives and the nucleoprotein N. The XCR1-targeting of N significantly improved the anti-N specific antibody response. Despite this immuno-potentiation, the DNA-MLV regimen did not further decrease the serum viral load or the nasal viral shedding of the challenge strain over MLV-alone. Finally, the heterologous protection, achieved in absence of detectable effective neutralizing antibodies, was not correlated to the measured antibody or to the IFNγ T-cell response. Therefore, immune correlates of protection remain to be identified and represent an important gap of knowledge in PRRSV vaccinology. This study importantly shows that a naked DNA prime immuno-potentiates an MLV, more on the B than on the IFNγ T-cell response side, and has to be further improved to reach cross-protection.
Collapse
Affiliation(s)
- Cindy Bernelin-Cottet
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Céline Urien
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Maxence Fretaud
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Christelle Langevin
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
- VIM, EMERG'IN-Plateforme d'Infectiologie Expérimentale IERP, INRA, Domaine de Vilvert, 78352 Jouy-en-Josas, France.
| | - Ivan Trus
- Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.
| | - Luc Jouneau
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Fany Blanc
- GABI, INRA-AgroParisTech, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Jean-Jacques Leplat
- GABI, INRA-AgroParisTech, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Céline Barc
- Plate-Forme d'Infectiologie Expérimentale-PFIE-UE1277, Centre Val de Loire, INRA, 37380 Nouzilly, France.
| | - Olivier Boulesteix
- Plate-Forme d'Infectiologie Expérimentale-PFIE-UE1277, Centre Val de Loire, INRA, 37380 Nouzilly, France.
| | - Mickaël Riou
- Plate-Forme d'Infectiologie Expérimentale-PFIE-UE1277, Centre Val de Loire, INRA, 37380 Nouzilly, France.
| | - Marilyn Dysart
- Pharmajet, 400 Corporate Circle Suite N, Golden, CO 80401, USA.
| | - Sophie Mahé
- Unité Virologie et Immunologie Porcines, Laboratoire de Ploufragan-Plouzané-Niort, Anses, BP 53, 22440 Ploufragan, France.
| | | | - Hans Nauwynck
- Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.
| | - Nicolas Bertho
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Olivier Bourry
- Unité Virologie et Immunologie Porcines, Laboratoire de Ploufragan-Plouzané-Niort, Anses, BP 53, 22440 Ploufragan, France.
| | | |
Collapse
|
6
|
Bernelin-Cottet C, Urien C, Stubsrud E, Jakob V, Bouguyon E, Bordet E, Barc C, Boulesteix O, Contreras V, Barnier-Quer C, Collin N, Trus I, Nauwynck H, Bertho N, Schwartz-Cornil I. A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus. Viruses 2019; 11:E551. [PMID: 31207934 PMCID: PMC6630347 DOI: 10.3390/v11060551] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Revised: 06/03/2019] [Accepted: 06/11/2019] [Indexed: 02/07/2023] Open
Abstract
The Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) induces reproductive disorders in sows and respiratory illnesses in growing pigs and is considered as one of the main pathogenic agents responsible for economic losses in the porcine industry worldwide. Modified live PRRSV vaccines (MLVs) are very effective vaccine types against homologous strains but they present only partial protection against heterologous viral variants. With the goal to induce broad and cross-protective immunity, we generated DNA vaccines encoding B and T antigens derived from a European subtype 1 strain that include T-cell epitope sequences known to be conserved across strains. These antigens were expressed either in a native form or in the form of vaccibodies targeted to the endocytic receptor XCR1 and CD11c expressed by different types of antigen-presenting cells (APCs). When delivered in skin with cationic nanoparticles and surface electroporation, multiple DNA vaccinations as a stand-alone regimen induced substantial antibody and T-cell responses, which were not promoted by targeting antigens to APCs. Interestingly, a DNA-MLV prime-boost strategy strongly enhanced the antibody response and broadened the T-cell responses over the one induced by MLV or DNA-only. The anti-nucleoprotein antibody response induced by the DNA-MLV prime-boost was clearly promoted by targeting the antigen to CD11c and XCR1, indicating a benefit of APC-targeting on the B-cell response. In conclusion, a DNA-MLV prime-boost strategy, by enhancing the potency and breadth of MLV vaccines, stands as a promising vaccine strategy to improve the control of PRRSV in infected herds.
Collapse
MESH Headings
- Animals
- Antibodies, Viral/blood
- Antibody Formation
- Immunity, Cellular
- Immunization Schedule
- Organisms, Genetically Modified/genetics
- Organisms, Genetically Modified/immunology
- Porcine Reproductive and Respiratory Syndrome/prevention & control
- Porcine respiratory and reproductive syndrome virus/genetics
- Porcine respiratory and reproductive syndrome virus/immunology
- Swine
- T-Lymphocytes/immunology
- Vaccines, Attenuated/administration & dosage
- Vaccines, Attenuated/genetics
- Vaccines, Attenuated/immunology
- Vaccines, DNA/administration & dosage
- Vaccines, DNA/genetics
- Vaccines, DNA/immunology
- Viral Vaccines/administration & dosage
- Viral Vaccines/genetics
- Viral Vaccines/immunology
Collapse
Affiliation(s)
- Cindy Bernelin-Cottet
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Céline Urien
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | | | - Virginie Jakob
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.
| | - Edwige Bouguyon
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Elise Bordet
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | - Céline Barc
- Plate-Forme d'Infectiologie Expérimentale-PFIE-UE1277, INRA, 37380 Nouzilly, France.
| | - Olivier Boulesteix
- Plate-Forme d'Infectiologie Expérimentale-PFIE-UE1277, INRA, 37380 Nouzilly, France.
| | - Vanessa Contreras
- Immunology of viral infections and autoimmune diseases, IDMIT Department, IBFJ, INSERM U1184-CEA-Université Paris Sud 11, 92260 Fontenay-Aux-Roses et 94270 Le Kremlin-Bicêtre, France.
| | - Christophe Barnier-Quer
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.
| | - Nicolas Collin
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.
| | - Ivan Trus
- Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.
| | - Hans Nauwynck
- Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.
| | - Nicolas Bertho
- VIM, INRA, Université Paris-Saclay, Domaine de Vilvert, 78350 Jouy-en-Josas, France.
| | | |
Collapse
|
7
|
Guillon A, Darrouzain F, Heuzé-Vourc'h N, Petitcollin A, Barc C, Vecellio L, Cormier B, Lanotte P, Sarradin P, Dequin PF, Paintaud G, Ehrmann S. Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets. Pulm Pharmacol Ther 2019; 57:101807. [PMID: 31102741 DOI: 10.1016/j.pupt.2019.101807] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2018] [Revised: 04/12/2019] [Accepted: 05/14/2019] [Indexed: 02/07/2023]
Abstract
BACKGROUND Nebulization during mechanical ventilation is impeded by large extra-pulmonary drug deposition and long administration durations which currently limit implementation of inhaled antibiotic therapy. Direct intra-tracheal delivery using a sprayer represents an appealing alternative investigated in small animal models, but large animal data are lacking. METHODS Amikacin was administered through intravenous infusion (20 mg/kg), nebulization (60 mg/kg) and direct intra-tracheal spray (30 mg/kg) to 10 intubated piglets, in a randomized cross-over design. Amikacin concentrations were measured in the serum and pulmonary parenchyma. Anatomic deposition was investigated using immuno-histochemistry. RESULTS Spray delivery resulted in higher amikacin outputs than nebulization and infusion. Pulmonary inhaled delivery techniques yielded much higher lung concentrations and much lower serum concentrations than intravenous infusion. However, unlike nebulization and infusion, intra-tracheal spray delivery was associated with more than 100- and 1000-fold variability in lung concentrations between and within animals. Amikacin specific immuno-histochemistry showed consistent bronchial and alveolar drug deposition with all modalities. CONCLUSION Nebulization remains the most reliable and simple technique to deliver inhaled amikacin uniformly to the lung during mechanical ventilation. Further development of tracheal sprays is required to take advantage of potential benefits related to high drug output and low extra-pulmonary deposition in large animals.
Collapse
Affiliation(s)
- Antoine Guillon
- CHRU de Tours, Médecine Intensive Réanimation, INSERM CIC 1415, CRICS-Triggersep, Tours, France; Université de Tours, INSERM, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, Tours, France
| | | | - Nathalie Heuzé-Vourc'h
- Université de Tours, INSERM, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, Tours, France
| | | | - Céline Barc
- INRA Val de Loire, Plateforme d'infectiologie expérimentale, UE 1277, Nouzilly, France
| | - Laurent Vecellio
- Université de Tours, INSERM, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, Tours, France
| | | | - Philippe Lanotte
- CHRU de Tours, Bactériologie-Virologie, Tours, France; ISP, INRA, Université de Tours, UMR1282, F-37380, Nouzilly, France
| | - Pierre Sarradin
- INRA Val de Loire, Plateforme d'infectiologie expérimentale, UE 1277, Nouzilly, France
| | - Pierre-François Dequin
- CHRU de Tours, Médecine Intensive Réanimation, INSERM CIC 1415, CRICS-Triggersep, Tours, France; Université de Tours, INSERM, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, Tours, France
| | | | - Stephan Ehrmann
- CHRU de Tours, Médecine Intensive Réanimation, INSERM CIC 1415, CRICS-Triggersep, Tours, France; Université de Tours, INSERM, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, Tours, France.
| |
Collapse
|
8
|
Caballero I, Riou M, Hacquin O, Chevaleyre C, Barc C, Pezant J, Pinard A, Fassy J, Rezzonico R, Mari B, Heuzé-Vourc'h N, Pitard B, Vassaux G. Tetrafunctional Block Copolymers Promote Lung Gene Transfer in Newborn Piglets. Mol Ther Nucleic Acids 2019; 16:186-193. [PMID: 30897407 PMCID: PMC6426709 DOI: 10.1016/j.omtn.2019.02.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Revised: 02/15/2019] [Accepted: 02/15/2019] [Indexed: 12/21/2022]
Abstract
Tetrafunctional block copolymers are molecules capable of complexing DNA. Although ineffective in vitro, studies in mice have shown that the tetrafunctional block copolymer 704 is a more efficient lung gene transfer agent than the cationic liposome GL67A, previously used in a phase II clinical trial in cystic fibrosis patients. In the present study, we compared the gene transfer capacity of the 704-DNA formulation and a cationic liposome-DNA formulation equivalent to GL67A in a larger-animal model, the newborn piglet. Our results indicate an efficacy of the 704-DNA formulation well above one order of magnitude higher than that of the cationic liposome-DNA formulation, with no elevated levels of interleukin-6 (IL-6), taken as a marker of inflammation. Transgene expression was heterogeneous within lung lobes, with expression levels that were below the detection threshold in some samples, while high in other samples. This heterogeneity is likely to be due to the bolus injection procedure as well as to the small volume of injection. The present study highlights the potential of tetrafunctional block copolymers as non-viral vectors for lung gene therapy.
Collapse
Affiliation(s)
- Ignacio Caballero
- INRA Centre Val de Loire - Université de Tours, UMR-1282 Infectiologie et Santé Publique (ISP), 37380 Nouzilly, France
| | - Mickaël Riou
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France
| | - Océane Hacquin
- Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France
| | - Claire Chevaleyre
- INRA Centre Val de Loire - Université de Tours, UMR-1282 Infectiologie et Santé Publique (ISP), 37380 Nouzilly, France
| | - Céline Barc
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France
| | - Jérémy Pezant
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France
| | - Anne Pinard
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France
| | - Julien Fassy
- Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France
| | - Roger Rezzonico
- Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France
| | - Bernard Mari
- Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France
| | | | - Bruno Pitard
- CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France
| | - Georges Vassaux
- Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France.
| |
Collapse
|
9
|
Laloy E, Bréard E, Trapp S, Pozzi N, Riou M, Barc C, Breton S, Delaunay R, Cordonnier N, Chateau-Joubert S, Crochet D, Gouzil J, Hébert T, Raimbourg M, Viarouge C, Vitour D, Durand B, Ponsart C, Zientara S. Fetopathic effects of experimental Schmallenberg virus infection in pregnant goats. Vet Microbiol 2017; 211:141-149. [PMID: 29102110 DOI: 10.1016/j.vetmic.2017.10.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Revised: 10/05/2017] [Accepted: 10/06/2017] [Indexed: 10/18/2022]
Abstract
Schmallenberg virus (SBV) is an emerging virus responsible for congenital malformations in the offspring of domestic ruminants. It is speculated that infection of pregnant dams may also lead to a significant number of unrecognized fetal losses during the early period of gestation. To assess the pathogenic effects of SBV infection of goats in early pregnancy, we inoculated dams at day 28 or 42 of gestation and followed the animals until day 55 of gestation. Viremia in the absence of clinical signs was detected in all virus-inoculated goats. Fetal deaths were observed in several goats infected at day 28 or 42 of gestation and were invariably associated with the presence of viral genomic RNA in the affected fetuses. Among the viable fetuses, two displayed lesions in the central nervous system (porencephaly) in the presence of viral genome and antigen. All fetuses from goats infected at day 42 and the majority of fetuses from goats infected at day 28 of gestation contained viral genomic RNA. Viral genome was widely distributed in these fetuses and their respective placentas, and infectious virus could be isolated from several organs and placentomes of the viable fetuses. Our results show that fetuses of pregnant goats are susceptible to vertical SBV infection during early pregnancy spanning at least the period between day 28 and 42 of gestation. The outcomes of experimental SBV infection assessed at day 55 of gestation include fetal mortalities, viable fetuses displaying lesions of the central nervous system, as well as viable fetuses without any detectable lesion.
Collapse
Affiliation(s)
- Eve Laloy
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité d'anatomie pathologique, 7 avenue du Général de Gaulle, 94704 Maisons-Alfort, France; Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France.
| | - Emmanuel Bréard
- Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France
| | - Sascha Trapp
- INRA Centre Val de Loire, UMR 1282 Infectiologie et Santé Publique, 37380 Nouzilly, France; Université François Rabelais de Tours, UMR 1282 Infectiologie et Santé Publique, 37000 Tours, France
| | - Nathalie Pozzi
- LNCR, Laboratoire national de contrôle des reproducteurs, 13, rue Jouët, 94703 Maisons-Alfort, France
| | - Mickaël Riou
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380 Nouzilly, France
| | - Céline Barc
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380 Nouzilly, France
| | - Sylvain Breton
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380 Nouzilly, France
| | - Rémi Delaunay
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380 Nouzilly, France
| | - Nathalie Cordonnier
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité d'anatomie pathologique, 7 avenue du Général de Gaulle, 94704 Maisons-Alfort, France; Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France
| | - Sophie Chateau-Joubert
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité d'anatomie pathologique, 7 avenue du Général de Gaulle, 94704 Maisons-Alfort, France
| | - Didier Crochet
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380 Nouzilly, France
| | - Julie Gouzil
- Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France
| | - Typhaine Hébert
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité d'anatomie pathologique, 7 avenue du Général de Gaulle, 94704 Maisons-Alfort, France
| | - Maxime Raimbourg
- LNCR, Laboratoire national de contrôle des reproducteurs, 13, rue Jouët, 94703 Maisons-Alfort, France
| | - Cyril Viarouge
- Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France
| | - Damien Vitour
- Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France
| | - Benoît Durand
- Université Paris-Est, ANSES, Laboratoire de Santé Animale, 14 rue Pierre et Marie Curie, 94700 Maisons-Alfort, France
| | - Claire Ponsart
- LNCR, Laboratoire national de contrôle des reproducteurs, 13, rue Jouët, 94703 Maisons-Alfort, France
| | - Stéphan Zientara
- Université Paris-Est, ANSES, Laboratoire de Santé Animale, UMR 1161 Virologie ANSES-INRA-ENVA, 14 rue Pierre et Marie Curie, 94704 Maisons-Alfort, France
| |
Collapse
|
10
|
Deloizy C, Fossum E, Barnier-Quer C, Urien C, Chrun T, Duval A, Codjovi M, Bouguyon E, Maisonnasse P, Hervé PL, Barc C, Boulesteix O, Pezant J, Chevalier C, Collin N, Dalod M, Bogen B, Bertho N, Schwartz-Cornil I. The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. Sci Rep 2017; 7:7639. [PMID: 28794452 PMCID: PMC5550447 DOI: 10.1038/s41598-017-07372-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2017] [Accepted: 07/07/2017] [Indexed: 11/10/2022] Open
Abstract
XCR1 is selectively expressed on a conventional dendritic cell subset, the cDC1 subset, through phylogenetically distant species. The outcome of antigen-targeting to XCR1 may therefore be similar across species, permitting the translation of results from experimental models to human and veterinary applications. Here we evaluated in pigs the immunogenicity of bivalent protein structures made of XCL1 fused to the external portion of the influenza virus M2 proton pump, which is conserved through strains and a candidate for universal influenza vaccines. Pigs represent a relevant target of such universal vaccines as pigs can be infected by swine, human and avian strains. We found that cDC1 were the only cell type labeled by XCR1-targeted mCherry upon intradermal injection in pig skin. XCR1-targeted M2e induced higher IgG responses in seronegative and seropositive pigs as compared to non-targeted M2e. The IgG response was less significantly enhanced by CpG than by XCR1 targeting, and CpG did not further increase the response elicited by XCR1 targeting. Monophosphoryl lipid A with neutral liposomes did not have significant effect. Thus altogether M2e-targeting to XCR1 shows promises for a trans-species universal influenza vaccine strategy, possibly avoiding the use of classical adjuvants.
Collapse
Affiliation(s)
- Charlotte Deloizy
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.,GenoSafe, 1 bis rue de l'International, 91000, Evry, France
| | - Even Fossum
- K.G. Jebsen Center for Influenza Vaccine Research, University of Oslo and Oslo University Hospital, 0027, Oslo, Norway
| | - Christophe Barnier-Quer
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066, Epalinges, Switzerland
| | - Céline Urien
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France
| | - Tiphany Chrun
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France
| | - Audrey Duval
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.,Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay, 78180, Montigny-le-Bretonneux, France
| | - Maelle Codjovi
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.,Genfit, 885 Avenue Eugène Avinée, 59120, Loos, France
| | - Edwige Bouguyon
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France
| | - Pauline Maisonnasse
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.,CEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral infections and Autoimmune Diseases (IMVA), IDMIT infrastructure, 92265 Fontenay-aux-Roses, France
| | - Pierre-Louis Hervé
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.,DBV Technologies, 177-181 avenue Pierre Brossolette, 92120, Montrouge, France
| | - Céline Barc
- UE1277-INRA, Plate-Forme d'Infectiologie Expérimentale - PFIE, 37380, Nouzilly, France
| | - Olivier Boulesteix
- UE1277-INRA, Plate-Forme d'Infectiologie Expérimentale - PFIE, 37380, Nouzilly, France
| | - Jérémy Pezant
- UE1277-INRA, Plate-Forme d'Infectiologie Expérimentale - PFIE, 37380, Nouzilly, France
| | - Christophe Chevalier
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France
| | - Nicolas Collin
- Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066, Epalinges, Switzerland
| | - Marc Dalod
- Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, 13288, Marseille, France
| | - Bjarne Bogen
- K.G. Jebsen Center for Influenza Vaccine Research, University of Oslo and Oslo University Hospital, 0027, Oslo, Norway.,Center for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, 0424, Oslo, Norway
| | - Nicolas Bertho
- VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France
| | | |
Collapse
|
11
|
Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, Boulesteix O, Pezant J, Richard CA, Moudjou M, Costa BD, Jouneau L, Chevalier C, Leclerc C, Sebo P, Bertho N, Schwartz-Cornil I. Corrigendum: A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies. Front Immunol 2017; 8:831. [PMID: 28740498 PMCID: PMC5513945 DOI: 10.3389/fimmu.2017.00831] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Accepted: 06/30/2017] [Indexed: 11/13/2022] Open
Abstract
[This corrects the article on p. 641 in vol. 7, PMID: 28082980.].
Collapse
Affiliation(s)
| | | | - Ondrej Stanek
- Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech Republic
| | - Céline Barc
- INRA, UE1277, Plate-Forme d'Infectiologie Expérimentale PFIE, Nouzilly, France
| | | | - Céline Urien
- VIM-INRA-Université Paris-Saclay, Jouy-en-Josas, France
| | - Olivier Boulesteix
- INRA, UE1277, Plate-Forme d'Infectiologie Expérimentale PFIE, Nouzilly, France
| | - Jérémy Pezant
- INRA, UE1277, Plate-Forme d'Infectiologie Expérimentale PFIE, Nouzilly, France
| | | | | | | | - Luc Jouneau
- VIM-INRA-Université Paris-Saclay, Jouy-en-Josas, France
| | | | - Claude Leclerc
- Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, Paris, France.,INSERM U1041, Unité de Régulation Immunitaire et Vaccinologie, Département Immunologie, Paris, France
| | - Peter Sebo
- Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech Republic
| | | | | |
Collapse
|
12
|
Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, Boulesteix O, Pezant J, Richard CA, Moudjou M, Da Costa B, Jouneau L, Chevalier C, Leclerc C, Sebo P, Bertho N, Schwartz-Cornil I. A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies. Front Immunol 2016; 7:641. [PMID: 28082980 PMCID: PMC5183740 DOI: 10.3389/fimmu.2016.00641] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2016] [Accepted: 12/12/2016] [Indexed: 12/24/2022] Open
Abstract
The development of influenza A virus (IAV) vaccines, which elicits cross-strain immunity against seasonal and pandemic viruses is a major public health goal. As pigs are susceptible to human, avian, and swine-adapted IAV, they would be key targets of so called universal IAV vaccines, for reducing both the zoonotic risk and the economic burden in the swine industry. They also are relevant preclinical models. However, vaccination with conserved IAV antigens (AGs) in pigs was reported to elicit disease exacerbation. In this study, we assessed whether delivery strategies, i.e., dendritic cell (DC) targeting by the intradermal (ID) or intramuscular (IM) routes, impact on the outcome of the vaccination with three conserved IAV AGs (M2e, NP, and HA2) in pigs. The AGs were addressed to CD11c by non-covalent binding to biotinylated anti-CD11c monoclonal antibody. The CD11c-targeted AGs given by the ID route exacerbated disease. Conversely, CD11c-targeted NP injected by the IM route promoted T cell response compared to non-targeted NP. Furthermore, the conserved IAV AGs injected by the IM route, independently of DC targeting, induced both a reduction of viral shedding and a broader IgG response as compared to the ID route. Our findings highlight in a relevant animal species that the route of vaccine delivery impacts on the protection induced by conserved IAV AGs and on vaccine adverse effects. Finally, our results indicate that HA2 stands as the most promising conserved IAV AG for universal vaccine development.
Collapse
Affiliation(s)
| | | | - Ondrej Stanek
- Institute of Microbiology of the Czech Academy of Sciences, v.v.i , Prague , Czech Republic
| | - Céline Barc
- INRA, UE1277, Plate-Forme d'Infectiologie Expérimentale, PFIE , Nouzilly , France
| | | | - Céline Urien
- VIM-INRA-Université Paris-Saclay , Jouy-en-Josas , France
| | - Olivier Boulesteix
- INRA, UE1277, Plate-Forme d'Infectiologie Expérimentale, PFIE , Nouzilly , France
| | - Jérémy Pezant
- INRA, UE1277, Plate-Forme d'Infectiologie Expérimentale, PFIE , Nouzilly , France
| | | | | | - Bruno Da Costa
- VIM-INRA-Université Paris-Saclay , Jouy-en-Josas , France
| | - Luc Jouneau
- VIM-INRA-Université Paris-Saclay , Jouy-en-Josas , France
| | | | - Claude Leclerc
- Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, Paris, France; INSERM U1041, Unité de Régulation Immunitaire et Vaccinologie, Département Immunologie, Paris, France
| | - Peter Sebo
- Institute of Microbiology of the Czech Academy of Sciences, v.v.i , Prague , Czech Republic
| | - Nicolas Bertho
- VIM-INRA-Université Paris-Saclay , Jouy-en-Josas , France
| | | |
Collapse
|
13
|
Chevaleyre C, Riou M, Bréa D, Vandebrouck C, Barc C, Pezant J, Melo S, Olivier M, Delaunay R, Boulesteix O, Berthon P, Rossignol C, Burlaud Gaillard J, Becq F, Gauthier F, Si-Tahar M, Meurens F, Berri M, Caballero-Posadas I, Attucci S. The Pig: A Relevant Model for Evaluating the Neutrophil Serine Protease Activities during Acute Pseudomonas aeruginosa Lung Infection. PLoS One 2016; 11:e0168577. [PMID: 27992534 PMCID: PMC5161375 DOI: 10.1371/journal.pone.0168577] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2016] [Accepted: 12/02/2016] [Indexed: 12/18/2022] Open
Abstract
The main features of lung infection and inflammation are a massive recruitment of neutrophils and the subsequent release of neutrophil serine proteases (NSPs). Anti-infectious and/or anti-inflammatory treatments must be tested on a suitable animal model. Mice models do not replicate several aspects of human lung disease. This is particularly true for cystic fibrosis (CF), which has led the scientific community to a search for new animal models. We have shown that mice are not appropriate for characterizing drugs targeting neutrophil-dependent inflammation and that pig neutrophils and their NSPs are similar to their human homologues. We induced acute neutrophilic inflammatory responses in pig lungs using Pseudomonas aeruginosa, an opportunistic respiratory pathogen. Blood samples, nasal swabs and bronchoalveolar lavage fluids (BALFs) were collected at 0, 3, 6 and 24 h post-insfection (p.i.) and biochemical parameters, serum and BAL cytokines, bacterial cultures and neutrophil activity were evaluated. The release of proinflammatory mediators, biochemical and hematological blood parameters, cell recruitment and bronchial reactivity, peaked at 6h p.i.. We also used synthetic substrates specific for human neutrophil proteases to show that the activity of pig NSPs in BALFs increased. These proteases were also detected at the surface of lung neutrophils using anti-human NSP antibodies. Pseudomonas aeruginosa-induced lung infection in pigs results in a neutrophilic response similar to that described for cystic fibrosis and ventilator-associated pneumonia in humans. Altogether, this indicates that the pig is an appropriate model for testing anti-infectious and/or anti-inflammatory drugs to combat adverse proteolytic effects of neutrophil in human lung diseases.
Collapse
Affiliation(s)
- Claire Chevaleyre
- Infectiologie et Santé Publique (UMR 1282 ISP), INRA, Université Tours, Nouzilly, France
| | - Mickaël Riou
- Plateforme d'Infectiologie expérimentale (UE-1277 PFIE), INRA, Nouzilly, France
| | - Déborah Bréa
- INSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours cedex, France
| | - Clarisse Vandebrouck
- Laboratoire Signalisation et Transports Ioniques Membranaires, Université de Poitiers, Centre National de la Recherche Scientifique, Poitiers cedex, France
| | - Céline Barc
- Plateforme d'Infectiologie expérimentale (UE-1277 PFIE), INRA, Nouzilly, France
| | - Jérémy Pezant
- Plateforme d'Infectiologie expérimentale (UE-1277 PFIE), INRA, Nouzilly, France
| | - Sandrine Melo
- Infectiologie et Santé Publique (UMR 1282 ISP), INRA, Université Tours, Nouzilly, France
| | - Michel Olivier
- Infectiologie et Santé Publique (UMR 1282 ISP), INRA, Université Tours, Nouzilly, France
| | - Rémy Delaunay
- Plateforme d'Infectiologie expérimentale (UE-1277 PFIE), INRA, Nouzilly, France
| | - Olivier Boulesteix
- Plateforme d'Infectiologie expérimentale (UE-1277 PFIE), INRA, Nouzilly, France
| | - Patricia Berthon
- Infectiologie et Santé Publique (UMR 1282 ISP), INRA, Université Tours, Nouzilly, France
| | - Christelle Rossignol
- Infectiologie et Santé Publique (UMR 1282 ISP), INRA, Université Tours, Nouzilly, France
| | - Julien Burlaud Gaillard
- Département des Microscopies (Plateau technologique Analyse des systèmes Biologiques), Université François-Rabelais, Tours cedex, France
| | - Frédéric Becq
- Laboratoire Signalisation et Transports Ioniques Membranaires, Université de Poitiers, Centre National de la Recherche Scientifique, Poitiers cedex, France
| | - Francis Gauthier
- INSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours cedex, France
| | - Mustapha Si-Tahar
- INSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours cedex, France
| | - François Meurens
- BioEpAR, Oniris, Nantes Atlantic National College of Veterinary Medicine, Food Science and Engineering La Chantrerie, Nantes Cedex 3, France
| | - Mustapha Berri
- Infectiologie et Santé Publique (UMR 1282 ISP), INRA, Université Tours, Nouzilly, France
| | | | - Sylvie Attucci
- INSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours cedex, France
- * E-mail:
| |
Collapse
|
14
|
Laloy E, Riou M, Barc C, Belbis G, Bréard E, Breton S, Cordonnier N, Crochet D, Delaunay R, Moreau J, Pozzi N, Raimbourg M, Sarradin P, Trapp S, Viarouge C, Zientara S, Ponsart C. Schmallenberg virus: experimental infection in goats and bucks. BMC Vet Res 2015; 11:221. [PMID: 26297244 PMCID: PMC4546222 DOI: 10.1186/s12917-015-0516-4] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2015] [Accepted: 07/30/2015] [Indexed: 11/18/2022] Open
Abstract
Background Schmallenberg virus (SBV) is an emerging Orthobunyavirus of ruminant livestock species currently circulating in Europe. SBV causes a subclinical or mild disease in adult animals but vertical transmission to pregnant dams may lead to severe malformations in the offspring. Data on the onset of clinical signs, viremia and seroconversion in experimentally infected adult animals are available for cattle and sheep but are still lacking for goats. For a better understanding of the pathogenesis of SBV infection in adult ruminants, we carried out experimental infections in adult goats. Our specific objectives were: (i) to record clinical signs, viremia and seroconversion; (ii) to monitor viral excretion in the semen of infected bucks; (iii) to determine in which tissues SBV replication took place and virus-induced lesions developed. Results Four goats and two bucks were inoculated with SBV. Virus inoculation was followed by a short viremic phase lasting 3 to 4 days and a seroconversion occurring between days 7 and 14 pi in all animals. The inoculated goats did not display any clinical signs, gross lesions or histological lesions. Viral genomic RNA was found in one ovary but could not be detected in other organs. SBV RNA was not found in the semen samples collected from two inoculated bucks. Conclusions In the four goats and two bucks, the kinetics of viremia and seroconversion appeared similar to those previously described for sheep and cattle. Our limited set of data provides no evidence of viral excretion in buck semen.
Collapse
Affiliation(s)
- E Laloy
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité d'anatomie pathologique, 7 avenue du Général de Gaulle, 94704, Maisons-Alfort, France.
| | - M Riou
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - C Barc
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - G Belbis
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité de pathologie des animaux de production, 7 avenue du Général de Gaulle, 94704, Maisons-Alfort, France.
| | - E Bréard
- ANSES, UMR 1161 Virologie ANSES-INRA-ENVA, 23 avenue du Général de Gaulle, 94704, Maisons-Alfort, France.
| | - S Breton
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - N Cordonnier
- Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité d'anatomie pathologique, 7 avenue du Général de Gaulle, 94704, Maisons-Alfort, France.
| | - D Crochet
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - R Delaunay
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - J Moreau
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - N Pozzi
- LNCR, Laboratoire national de contrôle des reproducteurs, 13 rue Jouët, 94703, Maisons-Alfort, France.
| | - M Raimbourg
- LNCR, Laboratoire national de contrôle des reproducteurs, 13 rue Jouët, 94703, Maisons-Alfort, France.
| | - P Sarradin
- INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie Expérimentale, secteur 3, route de Crotelles, 37380, Nouzilly, France.
| | - S Trapp
- INRA Centre Val de Loire, UMR 1282 Infectiologie et Santé Publique, 37380, Nouzilly, France. .,Université François Rabelais de Tours, UMR 1282 Infectiologie et Santé Publique, 37000, Tours, France.
| | - C Viarouge
- ANSES, UMR 1161 Virologie ANSES-INRA-ENVA, 23 avenue du Général de Gaulle, 94704, Maisons-Alfort, France.
| | - S Zientara
- ANSES, UMR 1161 Virologie ANSES-INRA-ENVA, 23 avenue du Général de Gaulle, 94704, Maisons-Alfort, France.
| | - C Ponsart
- LNCR, Laboratoire national de contrôle des reproducteurs, 13 rue Jouët, 94703, Maisons-Alfort, France.
| |
Collapse
|
15
|
Sarradin P, Viglietta C, Limouzin C, Andréoletti O, Daniel-Carlier N, Barc C, Leroux-Coyau M, Berthon P, Chapuis J, Rossignol C, Gatti JL, Belghazi M, Labas V, Vilotte JL, Béringue V, Lantier F, Laude H, Houdebine LM. Transgenic Rabbits Expressing Ovine PrP Are Susceptible to Scrapie. PLoS Pathog 2015; 11:e1005077. [PMID: 26248157 PMCID: PMC4527776 DOI: 10.1371/journal.ppat.1005077] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2015] [Accepted: 07/08/2015] [Indexed: 12/26/2022] Open
Abstract
Transmissible spongiform encephalopathies (TSEs) are a group of neurodegenerative diseases affecting a wide range of mammalian species. They are caused by prions, a proteinaceous pathogen essentially composed of PrPSc, an abnormal isoform of the host encoded cellular prion protein PrPC. Constrained steric interactions between PrPSc and PrPC are thought to provide prions with species specificity, and to control cross-species transmission into other host populations, including humans. Transgenetic expression of foreign PrP genes has been successfully and widely used to overcome the recognized resistance of mouse to foreign TSE sources. Rabbit is one of the species that exhibit a pronounced resistance to TSEs. Most attempts to infect experimentally rabbit have failed, except after inoculation with cell-free generated rabbit prions. To gain insights on the molecular determinants of the relative resistance of rabbits to prions, we generated transgenic rabbits expressing the susceptible V136R154Q171 allele of the ovine PRNP gene on a rabbit wild type PRNP New Zealand background and assessed their experimental susceptibility to scrapie prions. All transgenic animals developed a typical TSE 6-8 months after intracerebral inoculation, whereas wild type rabbits remained healthy more than 700 days after inoculation. Despite the endogenous presence of rabbit PrPC, only ovine PrPSc was detectable in the brains of diseased animals. Collectively these data indicate that the low susceptibility of rabbits to prion infection is not enciphered within their non-PrP genetic background.
Collapse
Affiliation(s)
- Pierre Sarradin
- INRA-Université de Tours, UMR1282, Infectiologie et Santé Publique, ISP, Nouzilly, France
- INRA, UE1277, Plate-Forme d’Infectiologie Expérimentale, PFIE, Nouzilly, France
- * E-mail: (PS); (VB)
| | - Céline Viglietta
- INRA-CNRS-ENVA, UMR1198, Biologie du Développement et Reproduction, BDR, Jouy-en-Josas, France
| | - Claude Limouzin
- INRA, UE1277, Plate-Forme d’Infectiologie Expérimentale, PFIE, Nouzilly, France
| | | | - Nathalie Daniel-Carlier
- INRA-CNRS-ENVA, UMR1198, Biologie du Développement et Reproduction, BDR, Jouy-en-Josas, France
| | - Céline Barc
- INRA-Université de Tours, UMR1282, Infectiologie et Santé Publique, ISP, Nouzilly, France
- INRA, UE1277, Plate-Forme d’Infectiologie Expérimentale, PFIE, Nouzilly, France
| | - Mathieu Leroux-Coyau
- INRA-CNRS-ENVA, UMR1198, Biologie du Développement et Reproduction, BDR, Jouy-en-Josas, France
| | - Patricia Berthon
- INRA-Université de Tours, UMR1282, Infectiologie et Santé Publique, ISP, Nouzilly, France
| | - Jérôme Chapuis
- INRA, UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France
| | - Christelle Rossignol
- INRA-Université de Tours, UMR1282, Infectiologie et Santé Publique, ISP, Nouzilly, France
| | - Jean-Luc Gatti
- INRA- CNRS-UNS, UMR1355, Institut Sophia Agrobiotech, ISA, Sophia Antipolis, France
- INRA, UMR INRA85, UMR CNRS 7247, Université de Tours, Institut Français du Cheval et de l’Equitation, Physiologie de la Reproduction et des Comportements, Plate-forme d’Analyse Intégrative des Biomolécules, Nouzilly, France
| | - Maya Belghazi
- INRA, UMR INRA85, UMR CNRS 7247, Université de Tours, Institut Français du Cheval et de l’Equitation, Physiologie de la Reproduction et des Comportements, Plate-forme d’Analyse Intégrative des Biomolécules, Nouzilly, France
- CNRS-Aix-Marseille Université, UMR7286, Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille, CRN2M, Marseille, France
| | - Valérie Labas
- CNRS-Aix-Marseille Université, UMR7286, Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille, CRN2M, Marseille, France
| | - Jean-Luc Vilotte
- INRA, UMR1313, Génétique Animale et Biologie Intégrative, Jouy-en-Josas, France
| | - Vincent Béringue
- INRA, UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France
- * E-mail: (PS); (VB)
| | - Frédéric Lantier
- INRA-Université de Tours, UMR1282, Infectiologie et Santé Publique, ISP, Nouzilly, France
| | - Hubert Laude
- INRA, UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France
| | - Louis-Marie Houdebine
- INRA-CNRS-ENVA, UMR1198, Biologie du Développement et Reproduction, BDR, Jouy-en-Josas, France
| |
Collapse
|
16
|
Guillon A, Mercier E, Lanotte P, Haguenoer E, Darrouzain F, Barc C, Sarradin P, Si-Tahar M, Heuzé-Vourc'h N, Diot P, Vecellio L. Aerosol Route to Administer Teicoplanin in Mechanical Ventilation: In Vitro Study, Lung Deposition and Pharmacokinetic Analyses in Pigs. J Aerosol Med Pulm Drug Deliv 2015; 28:290-8. [PMID: 25616054 DOI: 10.1089/jamp.2014.1164] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKROUND Glycopeptides given intravenously achieve low airway concentrations. Nebulization of teicoplanin may be an efficient way of delivering a high concentration of this antibiotic to the lung. This multistep study assessed the feasibility of teicoplanin nebulization during mechanical ventilation by evaluating: the stability of its antibiotic effect; epithelial tolerance; lung deposition and systemic absorption in ventilated pigs. METHODS Nebulized and non-nebulized teicoplanin activity was tested on Staphylococcus aureus cultures. The cytotoxic effect of teicoplanin on human respiratory epithelial cells was assessed by measuring lactate dehydrogenase activity released, cell viability, and transepithelial electrical resistance. Volume median diameter of particles of nebulized teicoplanin was measured by laser diffraction during mechanical ventilation. The deposited mass of teicoplanin nebulized with a vibrating mesh nebulizer in ventilated piglets was assessed by scintigraphy. Blood pharmacokinetics of teicoplanin administered either intravenously or by nebulization was compared. RESULTS No decrease of antibiotic activity was observed after nebulization. In vitro cytotoxicity of teicoplanin was only observed with 1000 times the dose recommended for intravenous administration. Volume median diameter of particles was 2.5±0.1 μm. Of the initial nebulizer charge of teicoplanin, 24±7% was present in the lungs of ventilated pigs after the nebulization. Amount absorbed in blood was low (3.4%±0.9%) after nebulization, and blood stream elimination half-life value was 25.4 h. CONCLUSIONS Teicoplanin was administered efficiently by nebulization during mechanical ventilation, without any effect on its pharmacological properties or any cytotoxicity. The pharmacokinetic parameters are promising in view of its time-dependent killing process. All the results of our multi-step study highlighted the potential of teicoplanin to be nebulized during mechanical ventilation.
Collapse
Affiliation(s)
- Antoine Guillon
- 1 Université François Rabelais de Tours , EA6305, Tours, France .,2 INSERM, U1100, Centre d'Etude des Pathologies Respiratoires , Tours, France .,3 CHRU de Tours, Service de Réanimation Polyvalente , Tours, France
| | - Emmanuelle Mercier
- 1 Université François Rabelais de Tours , EA6305, Tours, France .,2 INSERM, U1100, Centre d'Etude des Pathologies Respiratoires , Tours, France .,3 CHRU de Tours, Service de Réanimation Polyvalente , Tours, France
| | - Philippe Lanotte
- 4 Université François Rabelais de Tours , UMR1282 ISP, Tours, France .,5 INRA , UMR 1282 ISP, Nouzilly, France .,6 Service de Bactériologie-Virologie , Tours, France
| | - Eve Haguenoer
- 4 Université François Rabelais de Tours , UMR1282 ISP, Tours, France .,6 Service de Bactériologie-Virologie , Tours, France
| | | | - Céline Barc
- 8 INRA , UE1277, Plate-Forme d'Infectiologie Expérimentale, Nouzilly, France
| | - Pierre Sarradin
- 8 INRA , UE1277, Plate-Forme d'Infectiologie Expérimentale, Nouzilly, France
| | - Mustapha Si-Tahar
- 1 Université François Rabelais de Tours , EA6305, Tours, France .,2 INSERM, U1100, Centre d'Etude des Pathologies Respiratoires , Tours, France
| | - Nathalie Heuzé-Vourc'h
- 1 Université François Rabelais de Tours , EA6305, Tours, France .,2 INSERM, U1100, Centre d'Etude des Pathologies Respiratoires , Tours, France
| | - Patrice Diot
- 1 Université François Rabelais de Tours , EA6305, Tours, France .,2 INSERM, U1100, Centre d'Etude des Pathologies Respiratoires , Tours, France
| | - Laurent Vecellio
- 1 Université François Rabelais de Tours , EA6305, Tours, France .,9 Aerodrug, Université François Rabelais , Faculté de Médecine, Tours, France
| |
Collapse
|
17
|
Mankikian J, Ehrmann S, Guilleminault L, Le Fol T, Barc C, Ferrandière M, Boulain T, Dequin PF, Guillon A. An evaluation of a new single-use flexible bronchoscope with a large suction channel: reliability of bronchoalveolar lavage in ventilated piglets and initial clinical experience. Anaesthesia 2014; 69:701-6. [PMID: 24773281 DOI: 10.1111/anae.12641] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/20/2014] [Indexed: 11/27/2022]
Abstract
A single-use flexible bronchoscope with a large suction channel has become available recently and we have evaluated this innovative device. Firstly, bronchoalveolar lavage was performed and quantified in ventilated piglets. Next, the bronchoscope was evaluated in three intensive care units and a satisfaction questionnaire was carried out. Sixteen bronchoalveolar lavages were performed in piglets with a recovery rate of 83 (79-86 [72-89])% of the instilled volume. Quality and performance of all devices tested was identical. The medical satisfaction questionnaire was as follows: 'acceptable' to 'very good' for quality of aspiration, manoeuvrability and quality of vision; 'very good' to 'perfect' for setting up and insertion. This encouraging preliminary evaluation demonstrates the effectiveness of this new single-use device, which may obviate the need for disinfection procedures and, thereby, eradicate a potential vector of patient cross-contamination.
Collapse
Affiliation(s)
- J Mankikian
- CHRU de Tours, Service de Réanimation Polyvalente, Tours, France
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Legros C, Chesneau D, Boutin JA, Barc C, Malpaux B. Melatonin from cerebrospinal fluid but not from blood reaches sheep cerebral tissues under physiological conditions. J Neuroendocrinol 2014; 26:151-63. [PMID: 24460899 DOI: 10.1111/jne.12134] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2013] [Revised: 01/15/2014] [Accepted: 01/20/2014] [Indexed: 11/29/2022]
Abstract
The pineal gland secretes melatonin (MLT) that circulates in the blood and cerebrospinal fluid (CSF). We provide data to support the hypothesis that, in sheep and possibly in humans, only the CSF MLT, and not the blood MLT, can provide most of MLT to the cerebral tissue in high concentrations, particularly in the periventricular area. The MLT content of sheep brain, our chosen animal model, was found in significant concentration gradients oriented from the ventricle (close to the CSF) to the cerebral tissue, with concentrations varying by a factor of 1-125. The highest concentrations were observed close to the ventricle wall, whereas the lowest concentrations were furthest from the ventricles (407.0 ± 71.5 pg/ml compared to 84.7 ± 5.2 pg/ml around the third ventricle). This concentration gradient was measured in brain tissue collected at mid-day and at the end of the night. Nocturnal concentrations were higher than daytime concentrations, reflecting the diurnal variation in the pineal gland. The concentration gradient was not detected when MLT was delivered to the brain via the bloodstream. The diffusion of MLT to cerebral tissues via CSF was supported by in vivo scintigraphy and autoradiography. 2-[(123)I]-MLT infused into the CSF quickly and efficiently diffused into the brain tissues, whereas [(123)I]-iodine (control) was mostly washed away by the CSF flow and [(123)I]-bovine serum albumin remained mostly in the CSF. Taken together, these data support a critical role of CSF in providing the brain with MLT.
Collapse
Affiliation(s)
- C Legros
- INRA, UMR85 Physiologie de la Reproduction et des Comportements, Nouzilly, France; CNRS, UMR7247, Nouzilly, France; Université François Rabelais de Tours, Tours, France; IFCE, Nouzilly, France
| | | | | | | | | |
Collapse
|
19
|
Sarradin P, Melo S, Barc C, Lecomte C, Andréoletti O, Lantier F, Dacheux JL, Gatti JL. Semen from scrapie-infected rams does not transmit prion infection to transgenic mice. Reproduction 2008; 135:415-8. [PMID: 18299435 DOI: 10.1530/rep-07-0388] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Scrapie is the most common transmissible spongiform encephalopathy (TSE) in livestock. Natural contamination in sheep flocks is presumed to occur by maternal transmission to offspring. However, horizontal prion transmission from animal to animal exists and may be significant in sustaining and spreading contagion in the field. Artificial insemination is widely used in modern farming, and as large amounts of prion protein have been found in sheep sperm membrane, epididymal fluid and seminal plasma, horizontal transmission by this route was hypothesized since no clear information has been obtained on possible sexual transmission of TSE. We therefore tested the contamination levels of semen from scrapie-infected rams at different stages of incubation, including the clinical phase of the disease. We report here that under our experimental conditions ram semen did not transmit infectivity to scrapie-susceptible transgenic mice overexpressing the V(136)R(154)Q(171) allele of the sheep prion (PRNP) gene. These results suggest that artificial insemination and natural mating have a very low or negligible potential for the transmission of scrapie in sheep flocks.
Collapse
Affiliation(s)
- Pierre Sarradin
- INRA, UR1282, Infectiologie Animale et Santé Publique (IASP), Nouzilly F-37380, France
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Song PJ, Bernard S, Sarradin P, Vergote J, Barc C, Chalon S, Kung MP, Kung HF, Guilloteau D. IMPY, a potential β-amyloid imaging probe for detection of prion deposits in scrapie-infected mice. Nucl Med Biol 2008; 35:197-201. [DOI: 10.1016/j.nucmedbio.2007.10.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2007] [Accepted: 10/14/2007] [Indexed: 10/22/2022]
|
21
|
Andréoletti O, Morel N, Lacroux C, Rouillon V, Barc C, Tabouret G, Sarradin P, Berthon P, Bernardet P, Mathey J, Lugan S, Costes P, Corbière F, Espinosa JC, Torres JM, Grassi J, Schelcher F, Lantier F. Bovine spongiform encephalopathy agent in spleen from an ARR/ARR orally exposed sheep. J Gen Virol 2006; 87:1043-1046. [PMID: 16528056 DOI: 10.1099/vir.0.81318-0] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Oral contamination with bovine spongiform encephalopathy (BSE) agent in susceptible PRNP genotype sheep results in widespread distribution of prion in the host. Because ARR homozygous sheep are considered to be resistant to transmissible spongiform encephalopathies, they have been selected to eradicate scrapie from sheep flocks and to protect the human food chain from small ruminant BSE risk. However, results presented here show that several months after an oral challenge with BSE agent, healthy ARR/ARR sheep can accumulate significant amounts of PrP(Sc) in the spleen.
Collapse
Affiliation(s)
- Olivier Andréoletti
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Nathalie Morel
- CEA, Service de Pharmacologie et d'Immunologie, CEA/Saclay, 91191 Gif sur Yvette cedex, France
| | - Caroline Lacroux
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Virginie Rouillon
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Céline Barc
- INRA, Pathologie Infectieuse et Immunologie, INRA Nouzilly, 37380 Nouzilly, France
| | - Guillaume Tabouret
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Pierre Sarradin
- INRA, Pathologie Infectieuse et Immunologie, INRA Nouzilly, 37380 Nouzilly, France
| | - Patricia Berthon
- INRA, Pathologie Infectieuse et Immunologie, INRA Nouzilly, 37380 Nouzilly, France
| | - Philippe Bernardet
- INRA, Pathologie Infectieuse et Immunologie, INRA Nouzilly, 37380 Nouzilly, France
| | - Jacinthe Mathey
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Séverine Lugan
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Pierrette Costes
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Fabien Corbière
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Juan-Carlos Espinosa
- CISA, Instituto National de Investigacion y Tecnologia Agraria y Alimentaria, 28130 Valdeolmos, Spain
| | - Juan Maria Torres
- CISA, Instituto National de Investigacion y Tecnologia Agraria y Alimentaria, 28130 Valdeolmos, Spain
| | - Jacques Grassi
- CEA, Service de Pharmacologie et d'Immunologie, CEA/Saclay, 91191 Gif sur Yvette cedex, France
| | - François Schelcher
- UMR INRA ENVT 1225, Interactions Hôte-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France
| | - Frédéric Lantier
- INRA, Pathologie Infectieuse et Immunologie, INRA Nouzilly, 37380 Nouzilly, France
| |
Collapse
|